hBD-3 facilitates mDC-NK crosstalk (INC6P.348)
mDC and NK cells are involved in the innate immune response to pathogen, and bidirectional mDC-NK interactions are well described. hBD-3, an anti-microbial peptide, is known to activate mDC via TLR1/2. Here we investigated the effects of hBD-3 on mDC-NK interactions. We observed hBD-3 to activate PB...
Saved in:
Published in | The Journal of immunology (1950) Vol. 192; no. Supplement_1; pp. 121 - 121.15 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.05.2014
|
Online Access | Get full text |
ISSN | 0022-1767 1550-6606 |
DOI | 10.4049/jimmunol.192.Supp.121.15 |
Cover
Summary: | mDC and NK cells are involved in the innate immune response to pathogen, and bidirectional mDC-NK interactions are well described. hBD-3, an anti-microbial peptide, is known to activate mDC via TLR1/2. Here we investigated the effects of hBD-3 on mDC-NK interactions. We observed hBD-3 to activate PBMC to secrete IFN-γ and kill K562 and HUH hepatoma target cells in an mDC and NK dependent fashion, and both TLR1/2 and CCR2 were involved. In purified mDC-NK coculture experiments we observed hBD-3 to facilitate mDC and NK activation, IFNγ secretion, and killer activity. Activity was variable among healthy subject samples, in some cases dependent on TLR1/2, and in other cases dependent on CCR2. We observed TLR1/2 and CCR2 expression on both mDC and NK cells, with variability in expression among individuals. These results implicate hBD-3 in ability to directly activate NK cells, mDC, and facilitate mDC-NK interactions. HBD3 may therefore act as a mediator of innate cell interactions that result in bridging of innate and adaptive immunity. |
---|---|
ISSN: | 0022-1767 1550-6606 |
DOI: | 10.4049/jimmunol.192.Supp.121.15 |